Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled Trial

Introduction: Patients with Multiple Sclerosis exhibit disturbed dexterity, leading to difficulties in fine motor skills such as buttoning a T-shirt or hand-writing. Consequently, activities of daily living and quality of life are affected. The aim of the present study is to investigate the effectiv...

Full description

Bibliographic Details
Published in:	Frontiers in Neurology
Main Authors:	Judith J. W. van Beek, Erwin E. H. van Wegen, Cleo D. Bol, Marc B. Rietberg, Christian P. Kamm, Tim Vanbellingen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-02-01
Subjects:	randomized controlled trial app-based training dexterity multiple sclerosis arm function in multiple sclerosis questionnaire
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2019.00061/full

Similar Items

Usability of Videogame-Based Dexterity Training in the Early Rehabilitation Phase of Stroke Patients: A Pilot Study
by: Tim Vanbellingen, et al.
Published: (2017-12-01)

From Diagnosis to Satisfaction in Multiple Sclerosis: A Swiss Patient Survey Highlighting the Importance of the First Diagnostic Consultation
by: Christian P. Kamm, et al.
Published: (2022-01-01)

Fitts’ Tapping Task as a New Test for Cognition and Manual Dexterity in Multiple Sclerosis: Validation Study
by: Klaudia Duka Glavor, et al.
Published: (2022-12-01)

Effects of Transcranial Direct Current Stimulation on Hand Dexterity in Multiple Sclerosis: A Design for a Randomized Controlled Trial
by: Samar S. Ayache, et al.
Published: (2020-03-01)

HIITing Anxiety and Depression in Parkinson’s Disease and Multiple Sclerosis—A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT)
by: Arianne S. Gravesteijn, et al.
Published: (2025-08-01)

Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022
by: Christoph Friedli, et al.
Published: (2022-12-01)

A Usability Pilot Study of a Sensor-Guided Interactive System for Dexterity Training in Parkinson’s Disease
by: Nic Krummenacher, et al.
Published: (2025-02-01)

TERIFLUNOMIDE - A NEW TABLETED DRUG FOR THERAPY OF REMITTING DISSEMINATED SCLEROSIS (REVIEW)
by: E. V. POPOVA, et al.
Published: (2016-12-01)

Feasibility of a combined intermittent theta-burst stimulation and video game-based dexterity training in Parkinson’s disease
by: Manuela Pastore-Wapp, et al.
Published: (2023-01-01)

Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis
by: K. Z. Bakhtiyarova, et al.
Published: (2020-06-01)

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets
by: N. A. Totolyan, et al.
Published: (2020-10-01)

Cost–effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain
by: Ricardo Ginestal, et al.
Published: (2023-01-01)

An Accessible, Open-Source Dexterity Test: Evaluating the Grasping and Dexterous Manipulation Capabilities of Humans and Robots
by: Nathan Elangovan, et al.
Published: (2022-04-01)

Treatment Adherence in MS: Does Objective MS Knowledge and MS Risk Knowledge Matter in Relation to Perceived Disease-Modifying Therapy Benefits?
by: Edward Smith, et al.
Published: (2025-08-01)

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease
by: Carmen Lienert, et al.
Published: (2013-05-01)

Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review
by: Federico Carlini, et al.
Published: (2023-07-01)

Glucagon-like peptide-1 analogue, liraglutide, delays onset and reduces severity of experimental autoimmune encephalitis in Lewis rats
by: Brian DellaValle, et al.
Published: (2016-11-01)

Clinical Characteristics of Early-Onset and Late-Onset Multiple Sclerosis in Patients from Lithuania
by: Emilija Šlajūtė, et al.
Published: (2025-01-01)

Clinical markers for unfavorable course of multiple sclerosis
by: Mariya S. Matrosova, et al.
Published: (2023-09-01)

The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case–control study
by: Saeed Vaheb, et al.
Published: (2024-10-01)

Tumefactive: A Rare First presentation of Multiple Sclerosis
by: Athena Sharifi Razavi, et al.
Published: (2018-07-01)

Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients
by: Robert A. Brown, et al.
Published: (2014-01-01)

A Delphi study to identify key gait patterns and their potential causes in people with multiple sclerosis
by: Sjoerd T. Timmermans, et al.
Published: (2025-06-01)

Mobile App Interventions for Parkinson’s Disease, Multiple Sclerosis and Stroke: A Systematic Literature Review
by: Andreas Triantafyllidis, et al.
Published: (2023-03-01)

The use of cladribine tablets in patients with MS beyond the age of 50: experiences from a large tertiary German centre
by: Franziska Axhausen, et al.
Published: (2026-06-01)

Changes in retinal structures as markers of multiple sclerosis progression
by: M. O. Poplyak, et al.
Published: (2021-12-01)

Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease
by: Qiying Ye, et al.
Published: (2026-04-01)

Molecular Study of IL-7R Gene Polymorphism and their Associations with Male Multiple Sclerosis Patients in Erbil Province.
by: Shukur W. Smail
Published: (2021-02-01)

Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region
by: V. B. Laskov, et al.
Published: (2017-03-01)

Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021
by: Crystal Watson, et al.
Published: (2023-09-01)

The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis
by: Stephanie Rodgers, et al.
Published: (2021-06-01)

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
by: Katelijn M. Blok, et al.
Published: (2023-11-01)

Optimization of therapy in secondary progressive multiple sclerosis
by: A. N. Boyko, et al.
Published: (2024-08-01)

Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients
by: Shahrzad Mokhtari, et al.
Published: (2023-06-01)

Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study
by: Zahra Salehi, et al.
Published: (2024-06-01)

THE INVERSION OF HOMEOSTATIC PROPERTIES OF THE IMMUNE SYSTEM IN PATIENTS WITH MULTIPLE SCLEROSIS
by: I. I. Andreevа, et al.
Published: (2016-06-01)

Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents
by: M. D. Bogdanova, et al.
Published: (2020-08-01)

Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary‐progressive and relapsing‐remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases
by: Priyadarshi Prajjwal, et al.
Published: (2023-07-01)

Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
by: Barbara Polistena, et al.
Published: (2025-06-01)